Skip to Content
 

News: August, 2019

Cancer susceptibility genes

Saturday, August 31st, 2019

Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations.

Colorectal cancer researchers receive SPORE funding

Saturday, August 31st, 2019

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

New prostate cancer treatment concept

Friday, August 30th, 2019

Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

A “rheostat” for cancer signals

Friday, August 30th, 2019

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

Pancreatic cancer clue

Friday, August 30th, 2019

Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

Protein’s role in inflammation-related cancer studied

Friday, August 30th, 2019

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.

Potential second-line melanoma treatment identified

Friday, August 30th, 2019

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

New window on fibrosis

Friday, August 9th, 2019

A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.

Colorectal cancer patients warn against dismissing early symptoms

Friday, August 9th, 2019

Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.

Next Page »